ArasClin is a profitable Canadian company founded in 2014, providing clinical research and pharmaceutical consulting to the pharmaceutical and biotech companies in North America, Australia and Middle East countries. It provides high quality service in regulatory, Clinical development, trial management and pharmacovigilance.
Arasclin has provided and managed services directly or in partnership with other local Contract research Organizations for several clients; this ranging from multi-national pharmaceutical companies to small sized organizations.
We have local team in Canada, Australia , Turkey and UAE and trusted partner companies in Middle East which is a naïve and new emerging market for clinical research with large trials subjects.
Now ArasClin provides the clinical research and regulatory consulting service for Middle East pharmaceutical companies to obtain EMEA and other country’s marketing authorization through expertise management team with several years’ experience in the global pharmaceutical and clinical research organizations.
With local expertise and focus on quality, Arasclin ensures high quality clinical trial conduct and registration on time and within budget. We delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and full solution for clinical development.
